{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:15:44Z","timestamp":1779387344972,"version":"3.53.1"},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Hodgkin lymphoma is one of the most common cancers in adolescents and young adults (AYAs), a population with distinct biological, clinical, and developmental characteristics. Yet care remains fragmented between pediatric and adult systems contributing to variability in treatment exposure and survivorship outcomes. We synthesized current evidence on AYA HL epidemiology, biology, treatment strategies, supportive care needs, long-term toxicity risk, and survivorship. AYAs have access to multiple efficacious treatment options with high cure rates, but long-term survivors face significant medical, psychosocial, and financial effects with notable risks for cardiopulmonary disease, secondary malignancies, fertility impairment, and unmet psychosocial needs. Harmonized pediatric-adult treatment frameworks, AYA-focused support, and developmentally tailored survivorship care are essential to improving outcomes for AYA HL survivors.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000830","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:00:18Z","timestamp":1779386418000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Adolescent and Young Adult Patients With Classical Hodgkin Lymphoma"],"prefix":"10.1097","volume":"32","author":[{"given":"Brittany C.","family":"Kimball","sequence":"first","affiliation":[{"name":"Department of Oncology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8915-3163","authenticated-orcid":false,"given":"Allison C.","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"Division of Hematology Medical Oncology, Mayo Clinic Arizona, Phoenix, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"R1-20260521","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/bjh.15532","article-title":"Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States","volume":"183","author":"Blum","year":"2018","journal-title":"Br J Haematol"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study","volume":"12","author":"Zhou","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R4-20260521","doi-asserted-by":"crossref","first-page":"20500","DOI":"10.1038\/s41598-024-69975-3","article-title":"Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020","volume":"14","author":"Aslani","year":"2024","journal-title":"Sci Rep"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"22634","DOI":"10.1038\/s41598-025-07472-x","article-title":"Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States","volume":"15","author":"Mousavi","year":"2025","journal-title":"Sci Rep"},{"key":"R6-20260521","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1200\/JCO.23.01799","article-title":"Classic Hodgkin lymphoma in adolescents and young adults","volume":"42","author":"Kelly","year":"2024","journal-title":"J Clin Oncol"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","article-title":"Characteristics of Hodgkin\u2019s lymphoma after infectious mononucleosis","volume":"349","author":"Hjalgrim","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAP.0b013e31805048fc","article-title":"Immunodeficiency-related Hodgkin lymphoma and its mimics","volume":"14","author":"Said","year":"2007","journal-title":"Adv Anat Pathol"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/aje\/kws212","article-title":"Perinatal and family risk factors for Hodgkin lymphoma in childhood through young adulthood","volume":"176","author":"Crump","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/ijc.29589","article-title":"Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: a Children\u2019s Oncology Group study","volume":"137","author":"Linabery","year":"2015","journal-title":"Int J Cancer"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"80073","DOI":"10.18632\/oncotarget.20684","article-title":"Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients","volume":"8","author":"Bigenwald","year":"2017","journal-title":"Oncotarget"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1002\/cncr.27684","article-title":"Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults","volume":"118","author":"Smith","year":"2012","journal-title":"Cancer"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"1515250","DOI":"10.3389\/fonc.2025.1515250","article-title":"Tumor-microenvironment and molecular biology of classic Hodgkin lymphoma in children, adolescents, and young adults","volume":"15","author":"Aoki","year":"2025","journal-title":"Front Oncol"},{"key":"R14-20260521","doi-asserted-by":"crossref","first-page":"e0124531","DOI":"10.1371\/journal.pone.0124531","article-title":"Macrophage polarization reflects T cell composition of tumor microenvironment in pediatric classical Hodgkin lymphoma and has impact on survival","volume":"10","author":"Barros","year":"2015","journal-title":"PLoS One"},{"key":"R15-20260521","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","article-title":"Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells","volume":"4","author":"Maura","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"R16-20260521","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000447080","article-title":"Lymphoma in adolescents and young adults","volume":"43","author":"Brugi\u00e8res","year":"2016","journal-title":"Prog Tumor Res"},{"key":"R17-20260521","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bjh.15640","article-title":"Current considerations in AYA Hodgkin lymphoma","volume":"184","author":"Crombie","year":"2019","journal-title":"Br J Haematol"},{"key":"R18-20260521","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/bjh.19985","article-title":"Should adolescents and young adults with Hodgkin lymphoma be treated as children or adults?","volume":"206","author":"Lew-Derivry","year":"2025","journal-title":"Br J Haematol"},{"key":"R19-20260521","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1002\/cam4.3138","article-title":"Treatment patterns and outcomes in adolescents and young adults with Hodgkin lymphoma in pediatric versus adult centers: an IMPACT Cohort Study","volume":"9","author":"Gupta","year":"2020","journal-title":"Cancer Med"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.30979","article-title":"Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children\u2019s Oncology Group (COG AHOD0031) comparative analysis","volume":"124","author":"Henderson","year":"2018","journal-title":"Cancer"},{"key":"R21-20260521","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa2405888","article-title":"Nivolumab+AVD in advanced-stage classic Hodgkin\u2019s lymphoma","volume":"391","author":"Herrera","year":"2024","journal-title":"N Engl J Med"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1200\/JCO.20.03286","article-title":"Excellent outcome for pediatric patients with high-risk Hodgkin lymphoma treated with brentuximab vedotin and risk-adapted residual node radiation","volume":"39","author":"Metzger","year":"2021","journal-title":"J Clin Oncol"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2206660","article-title":"Brentuximab Vedotin with chemotherapy in pediatric high-risk Hodgkin\u2019s lymphoma","volume":"387","author":"Castellino","year":"2022","journal-title":"N Engl J Med"},{"key":"R24-20260521","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2020.0750","article-title":"Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL Trial","volume":"6","author":"Br\u00f6ckelmann","year":"2020","journal-title":"JAMA Oncol"},{"key":"R25-20260521","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.21.01281","article-title":"Brentuximab vedotin plus AVD for first-line treatment of early-stage unfavorable Hodgkin lymphoma (BREACH): a multicenter, open-label, randomized, phase II trial","volume":"41","author":"Fornecker","year":"2023","journal-title":"J Clin Oncol"},{"key":"R26-20260521","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(24)01315-1","article-title":"Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial","volume":"404","author":"Borchmann","year":"2024","journal-title":"Lancet"},{"key":"R27-20260521","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/cncr.31519","article-title":"Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: a report from the Children\u2019s Oncology Group","volume":"124","author":"Keller","year":"2018","journal-title":"Cancer"},{"key":"R28-20260521","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/1055-9965.EPI-25-0049","article-title":"Trends in radiation use from 2004 to 2020 among adolescents and young adults with Hodgkin lymphoma","volume":"34","author":"Corrigan","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R29-20260521","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1200\/JCO.20.01186","article-title":"Impact of risk-adapted therapy for pediatric Hodgkin lymphoma on risk of long-term morbidity: a report from the childhood cancer survivor study","volume":"39","author":"Oeffinger","year":"2021","journal-title":"J Clin Oncol"},{"key":"R30-20260521","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J Clin Oncol"},{"key":"R31-20260521","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.23.01745","article-title":"Long-term follow-up of the response-adapted intergroup EORTC\/LYSA\/FIL H10 trial for localized Hodgkin lymphoma","volume":"42","author":"Federico","year":"2024","journal-title":"J Clin Oncol"},{"key":"R32-20260521","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood-2018-01-827246","article-title":"CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET","volume":"132","author":"Straus","year":"2018","journal-title":"Blood"},{"key":"R33-20260521","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(21)00470-8","article-title":"Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial","volume":"23","author":"Mauz-K\u00f6rholz","year":"2022","journal-title":"Lancet Oncol"},{"key":"R34-20260521","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14338\/IJPT-21-00011.1","article-title":"Comparative effectiveness of proton therapy versus photon radiotherapy in adolescents and young adults for classical Hodgkin lymphoma","volume":"8","author":"Bates","year":"2022","journal-title":"Int J Part Ther"},{"key":"R35-20260521","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.3390\/cancers15174269","article-title":"Proton therapy in the adolescent and young adult population","volume":"15","author":"Ahmed","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R36-20260521","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"R37-20260521","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1200\/JCO.18.01652","article-title":"Relapse risk and loss of lifetime after modern combined modality treatment of young patients with Hodgkin Lymphoma: a Nordic Lymphoma Epidemiology Group Study","volume":"37","author":"Biccler","year":"2019","journal-title":"J Clin Oncol"},{"key":"R38-20260521","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/annonc\/mdx005","article-title":"ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma","volume":"28","author":"Marr","year":"2017","journal-title":"Ann Oncol"},{"key":"R39-20260521","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/bjh.16491","article-title":"Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015","volume":"189","author":"Reedijk","year":"2020","journal-title":"Br J Haematol"},{"key":"R40-20260521","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/S2352-3026(21)00349-5","article-title":"Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children\u2019s oncology group trials","volume":"9","author":"Kahn","year":"2022","journal-title":"Lancet Haematol"},{"key":"R41-20260521","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin\u2019s disease: a randomised trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"key":"R42-20260521","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1182\/blood-2010-09-288373","article-title":"How I treat relapsed and refractory Hodgkin lymphoma","volume":"117","author":"Kuruvilla","year":"2011","journal-title":"Blood"},{"key":"R43-20260521","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2010.08455.x","article-title":"Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents","volume":"152","author":"Daw","year":"2011","journal-title":"Br J Haematol"},{"key":"R44-20260521","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaoncol.2024.5627","article-title":"Transplant-free approach in relapsed Hodgkin lymphoma in children, adolescents, and young adults: a nonrandomized clinical trial","volume":"11","author":"Daw","year":"2025","journal-title":"JAMA Oncol"},{"key":"R45-20260521","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamaoncol.2024.5648","article-title":"Transplant-free salvage therapy for low-risk relapsed pediatric Hodgkin lymphoma: a nonrandomized clinical trial","volume":"11","author":"Hoppe","year":"2025","journal-title":"JAMA Oncol"},{"key":"R46-20260521","doi-asserted-by":"crossref","first-page":"66","DOI":"10.6004\/jnccn.2018.0001","article-title":"Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Coccia","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"R47-20260521","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/bloodadvances.2021005557","article-title":"Hodgkin lymphoma and female fertility: a multicenter study in women treated with doxorubicin, bleomycin, vinblastine, and dacarbazine","volume":"7","author":"Machet","year":"2023","journal-title":"Blood Adv"},{"key":"R48-20260521","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10815-015-0636-6","article-title":"Fertility in young patients following treatment for Hodgkin\u2019s lymphoma: a single center survey","volume":"33","author":"Bolte\u017ear","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"R49-20260521","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2007-02-073544","article-title":"Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)","volume":"111","author":"Sieniawski","year":"2008","journal-title":"Blood"},{"key":"R50-20260521","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3324\/haematol.2011.045856","article-title":"Management of fertility in patients treated for Hodgkin\u2019s lymphoma","volume":"96","author":"Harel","year":"2011","journal-title":"Haematologica"},{"key":"R51-20260521","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","article-title":"Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials","volume":"31","author":"Behringer","year":"2013","journal-title":"J Clin Oncol"},{"key":"R52-20260521","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/jnci\/djaa194","article-title":"Long-term cause-specific mortality in Hodgkin lymphoma patients","volume":"113","author":"de Vries","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"R53-20260521","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"key":"R54-20260521","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/asheducation-2016.1.323","article-title":"Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment","volume":"2016","author":"van Leeuwen","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R55-20260521","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"R56-20260521","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1182\/blood-2006-07-034405","article-title":"Late cardiotoxicity after treatment for Hodgkin lymphoma","volume":"109","author":"Aleman","year":"2007","journal-title":"Blood"},{"key":"R57-20260521","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-8140(99)00026-2","article-title":"Ischemic heart disease after mantlefield irradiation for Hodgkin\u2019s disease in long-term follow-up","volume":"51","author":"Reinders","year":"1999","journal-title":"Radiother Oncol"},{"key":"R58-20260521","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study","volume":"99","author":"Swerdlow","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R61-20260521","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1161\/CIR.0000000000001308","article-title":"Cardiovascular toxicity in patients treated for childhood cancer: a scientific statement from the American Heart Association","volume":"151","author":"Ryan","year":"2025","journal-title":"Circulation"},{"key":"R62-20260521","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/bjh.19475","article-title":"Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: a Danish national cohort study","volume":"205","author":"Vandtved","year":"2024","journal-title":"Br J Haematol"},{"key":"R63-20260521","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1517\/14740338.2014.946901","article-title":"Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity","volume":"13","author":"J\u00f3na","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"R64-20260521","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"R65-20260521","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin\u2019s disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N Engl J Med"},{"key":"R66-20260521","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2013-07-512657","article-title":"Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"123","author":"Eichenauer","year":"2014","journal-title":"Blood"},{"key":"R67-20260521","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1016\/S2352-3026(23)00212-0","article-title":"Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study","volume":"10","author":"Trab","year":"2023","journal-title":"Lancet Haematol"},{"key":"R68-20260521","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1200\/JCO.2012.44.5791","article-title":"Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials","volume":"31","author":"Koontz","year":"2013","journal-title":"J Clin Oncol"},{"key":"R69-20260521","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djac125","article-title":"Radiotherapy-related dose and irradiated volume effects on breast cancer risk among Hodgkin lymphoma survivors","volume":"114","author":"Roberti","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"R70-20260521","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/jnci\/djae274","article-title":"Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma","volume":"117","author":"Roberti","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"R71-20260521","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1200\/JCO.23.01386","article-title":"Doxorubicin exposure and breast cancer risk in survivors of adolescent and adult Hodgkin lymphoma","volume":"42","author":"Neppelenbroek","year":"2024","journal-title":"J Clin Oncol"},{"key":"R72-20260521","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/pmrj.12662","article-title":"Prevalence of function-limiting late effects in Hodgkin lymphoma survivors","volume":"14","author":"Enam","year":"2022","journal-title":"Pm r"},{"key":"R73-20260521","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/annonc\/mdt568","article-title":"Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy","volume":"25","author":"Streckmann","year":"2014","journal-title":"Ann Oncol"},{"key":"R74-20260521","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.fertnstert.2019.09.013","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"112","year":"2019","journal-title":"Fertil Steril"},{"key":"R75-20260521","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fonc.2013.00075","article-title":"Unmet support service needs and health-related quality of life among adolescents and young adults with cancer: the AYA HOPE study","volume":"3","author":"Smith","year":"2013","journal-title":"Front Oncol"},{"key":"R76-20260521","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-8-25","article-title":"Measuring the psychosocial health of adolescent and young adult (AYA) cancer survivors: a critical review","volume":"8","author":"Clinton-McHarg","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"R77-20260521","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.2011.39.5467","article-title":"Psychosocial care of adolescent and young adult patients with cancer and survivors","volume":"30","author":"Zebrack","year":"2012","journal-title":"J Clin Oncol"},{"key":"R78-20260521","doi-asserted-by":"crossref","first-page":"e2136039","DOI":"10.1001\/jamanetworkopen.2021.36039","article-title":"Assessment of the promoting resilience in stress management intervention for adolescent and young adult survivors of cancer at 2 years: secondary analysis of a randomized clinical trial","volume":"4","author":"Rosenberg","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R79-20260521","doi-asserted-by":"crossref","first-page":"e6335","DOI":"10.1002\/pon.6335","article-title":"Acceptability, feasibility and preliminary effects of an online group psychotherapy intervention for adolescents and young adults with cancer","volume":"33","author":"Tutelman","year":"2024","journal-title":"Psychooncology"},{"key":"R80-20260521","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PPO.0000000000000339","article-title":"Psychosocial support in adolescents and young adults with cancer","volume":"24","author":"Penn","year":"2018","journal-title":"Cancer J"},{"key":"R81-20260521","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/CCO.0000000000001151","article-title":"Psychological interventions in adolescents and young adults with cancer: a scoping review targeting protective factors of resilience","volume":"37","author":"Servais","year":"2025","journal-title":"Curr Opin Oncol"},{"key":"R82-20260521","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/jayao.2020.0027","article-title":"Adolescents and young adults with cancer: barriers in access to psychosocial support","volume":"10","author":"Holland","year":"2021","journal-title":"J Adolesc Young Adult Oncol"},{"key":"R83-20260521","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MOP.0000000000001200","article-title":"Adolescent and young adult cancers: unmet needs and closing the gaps","volume":"35","author":"Berkman","year":"2023","journal-title":"Curr Opin Pediatr"},{"key":"R84-20260521","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1002\/cncr.30648","article-title":"Cost-related medication nonadherence among adolescent and young adult cancer survivors","volume":"123","author":"Kaul","year":"2017","journal-title":"Cancer"},{"key":"R85-20260521","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1200\/JCO-24-02121","article-title":"Long-term dynamic financial impacts among adolescents and young adults with cancer: a longitudinal matched-cohort study","volume":"43","author":"Di Giuseppe","year":"2025","journal-title":"J Clin Oncol"},{"key":"R86-20260521","doi-asserted-by":"crossref","first-page":"Op2500389","DOI":"10.1200\/OP-25-00389","article-title":"Financial Distress Screening and Financial Navigation Among Adolescents and Young Adults Within the National Cancer Institute Community Oncology Research Program: Results of the 2022 Landscape Survey","volume":"6","author":"Robles","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"R87-20260521","first-page":"434","article-title":"Do discussions of financial burdens decrease long-term financial toxicity in adolescent and young adult cancer survivors?","volume":"31","author":"Wu","year":"2023","journal-title":"Support Care Cancer"},{"key":"R88-20260521","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2018-01-778548","article-title":"The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice?","volume":"132","author":"Flerlage","year":"2018","journal-title":"Blood"},{"key":"R89-20260521","doi-asserted-by":"crossref","first-page":"e432420","DOI":"10.1200\/EDBK_432420","article-title":"Pediatric and adolescent Hodgkin lymphoma: paving the way for standards of care and shared decision making","volume":"44","author":"Kahn","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"R90-20260521","doi-asserted-by":"crossref","first-page":"e27991","DOI":"10.1002\/pbc.27991","article-title":"Models of care for adolescent and young adult cancer programs","volume":"66","author":"Osborn","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R91-20260521","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s11764-023-01397-y","article-title":"Primary care physicians\u2019 knowledge and confidence in providing cancer survivorship care: a systematic review","volume":"18","author":"Vos","year":"2024","journal-title":"J Cancer Surviv"},{"key":"R92-20260521","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/cncr.28685","article-title":"Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study","volume":"120","author":"Parsons","year":"2014","journal-title":"Cancer"},{"key":"R93-20260521","doi-asserted-by":"crossref","first-page":"e27883","DOI":"10.1002\/pbc.27883","article-title":"Things that matter: adolescent and young adult patients\u2019 priorities during cancer care","volume":"66","author":"Graetz","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R94-20260521","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1200\/JCO.23.01390","article-title":"Sexual health in adolescents and young adults with cancer","volume":"42","author":"Cherven","year":"2024","journal-title":"J Clin Oncol"},{"key":"R95-20260521","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/cancers14030710","article-title":"Psychosocial needs and preferences for care among adolescent and young adult cancer patients (ages 15-39): a qualitative study","volume":"14","author":"Avutu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R96-20260521","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2022.40.16_suppl.6569","article-title":"When and how to deliver oncology supportive care resources: an adolescent and young adult perspective","volume":"40","author":"Roggenkamp","year":"2022","journal-title":"J Clin Oncol"},{"key":"R97-20260521","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjmed.2011.01.013","article-title":"Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial","volume":"124","author":"Montori","year":"2011","journal-title":"Am J Med"},{"key":"R98-20260521","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.pec.2009.10.008","article-title":"The Statin Choice decision aid in primary care: a randomized trial","volume":"80","author":"Mann","year":"2010","journal-title":"Patient Educ Couns"},{"key":"R99-20260521","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1007\/s11606-024-09001-4","article-title":"Comparative effectiveness of decision aids for cancer-screening decision making: an overview of reviews","volume":"39","author":"Hibino","year":"2024","journal-title":"J Gen Intern Med"},{"key":"R100-20260521","doi-asserted-by":"crossref","first-page":"e2335941","DOI":"10.1001\/jamanetworkopen.2023.35941","article-title":"Effectiveness of a decision aid plus standard care in surgical management among patients with early breast cancer: a randomized clinical trial","volume":"6","author":"Joshi","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R101-20260521","first-page":"2983","article-title":"MyPref: pilot study of a novel communication and decision-making tool for adolescents and young adults with advanced cancer","volume":"29","author":"Snaman","year":"2021","journal-title":"Support Care Cancer"},{"key":"R102-20260521","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jnci\/djae119","article-title":"Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities","volume":"116","author":"Berkman","year":"2024","journal-title":"J Natl Cancer Inst"},{"key":"R103-20260521","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1016\/S1470-2045(25)00410-3","article-title":"Health-care transitions for young people living beyond childhood and adolescent cancer: recommendations from the EU-CAYAS-NET consortium","volume":"26","author":"Wams","year":"2025","journal-title":"Lancet Oncol"},{"key":"R104-20260521","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JOP.0934405","article-title":"Passport for care: implementing the survivorship care plan","volume":"5","author":"Horowitz","year":"2009","journal-title":"J Oncol Pract"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:00:31Z","timestamp":1779386431000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000830"}},"subtitle":["A Review as a Case Study in AYA Cancer Care"],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":101,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000830","relation":{},"ISSN":["1540-336X"],"issn-type":[{"value":"1540-336X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}